Adam Wylęgała

1.2k total citations
79 papers, 825 citations indexed

About

Adam Wylęgała is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Adam Wylęgała has authored 79 papers receiving a total of 825 indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Ophthalmology, 54 papers in Radiology, Nuclear Medicine and Imaging and 14 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Adam Wylęgała's work include Corneal surgery and disorders (35 papers), Glaucoma and retinal disorders (27 papers) and Retinal Diseases and Treatments (22 papers). Adam Wylęgała is often cited by papers focused on Corneal surgery and disorders (35 papers), Glaucoma and retinal disorders (27 papers) and Retinal Diseases and Treatments (22 papers). Adam Wylęgała collaborates with scholars based in Poland, United States and Italy. Adam Wylęgała's co-authors include Edward Wylęgała, Stephan Ong Tone, Dariusz Dobrowolski, Myriam Böhm, Sławomir Teper, Ula V. Jurkunas, Tomas White, Viridiana Kocaba, Michał Toborek and Minseon Park and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Adam Wylęgała

67 papers receiving 804 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam Wylęgała Poland 15 532 524 120 106 95 79 825
F. Sáenz-Francés Spain 16 670 1.3× 942 1.8× 160 1.3× 107 1.0× 79 0.8× 169 1.1k
Xinbo Gao China 17 422 0.8× 601 1.1× 81 0.7× 83 0.8× 134 1.4× 56 827
Alon Skaat Israel 17 588 1.1× 761 1.5× 82 0.7× 67 0.6× 88 0.9× 62 942
Kemal Örnek Türkiye 15 361 0.7× 469 0.9× 111 0.9× 52 0.5× 111 1.2× 84 755
Ahmet Akman Türkiye 17 435 0.8× 720 1.4× 142 1.2× 230 2.2× 60 0.6× 56 874
Manuel M. Hermann Germany 24 831 1.6× 1.1k 2.0× 135 1.1× 67 0.6× 173 1.8× 57 1.3k
Sare Safi Iran 15 411 0.8× 553 1.1× 83 0.7× 79 0.7× 138 1.5× 64 826
Lorenzo Ferro Desideri Italy 18 383 0.7× 544 1.0× 86 0.7× 88 0.8× 171 1.8× 86 850
Laura Morales‐Fernández Spain 19 702 1.3× 852 1.6× 172 1.4× 112 1.1× 104 1.1× 95 1.0k
Eray Atalay Türkiye 18 568 1.1× 584 1.1× 143 1.2× 59 0.6× 74 0.8× 73 790

Countries citing papers authored by Adam Wylęgała

Since Specialization
Citations

This map shows the geographic impact of Adam Wylęgała's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Wylęgała with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Wylęgała more than expected).

Fields of papers citing papers by Adam Wylęgała

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Wylęgała. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Wylęgała. The network helps show where Adam Wylęgała may publish in the future.

Co-authorship network of co-authors of Adam Wylęgała

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Wylęgała. A scholar is included among the top collaborators of Adam Wylęgała based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Wylęgała. Adam Wylęgała is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wylęgała, Adam, et al.. (2025). High‐resolution OCT and in vivo confocal microscopy in corneal epithelial disorders. Acta Ophthalmologica.
2.
Wylęgała, Edward, et al.. (2025). Variability in Corneal and Epithelial Pachymetry: A Comparison of Optopol Revo 130 and Optovue RTV XR Avanti in Healthy Patients. Journal of Clinical Medicine. 14(4). 1295–1295.
3.
Orzechowska-Wylęgała, Bogusława, Adam Wylęgała, Jolanta Zalejska–Fiolka, Zenon Czuba, & Michał Toborek. (2024). Saliva-Based Protein Analysis in Pediatric Dentofacial Inflammation. Pediatric Health Medicine and Therapeutics. Volume 15. 95–102. 1 indexed citations
4.
Wylęgała, Edward, et al.. (2024). Fuch’s Endothelial Corneal Dystrophy in Cataract Patients Is Associated with Elevated Levels of Inflammatory Chemokines, but Not Growth Factors, in the Aqueous Humor. International Journal of Molecular Sciences. 25(3). 1894–1894. 3 indexed citations
5.
Wylęgała, Adam, et al.. (2024). The level of cytokines in tears as a novel indicator of demyelinating diseases. Neurological Research. 46(6). 487–494. 1 indexed citations
6.
Wylęgała, Adam, et al.. (2024). Risk Factors for Glaucoma and Ocular Hypertension and Post-Transplant Complications in Keratoconus: A Multivariable Analysis. Journal of Clinical Medicine. 13(18). 5407–5407. 2 indexed citations
7.
Wylęgała, Adam, et al.. (2024). Artificial-Intelligence-Enhanced Analysis of In Vivo Confocal Microscopy in Corneal Diseases: A Review. Diagnostics. 14(7). 694–694. 6 indexed citations
8.
Roszkowska, Anna Maria, et al.. (2024). Salzmann Nodular Degeneration in Ocular and Systemic Diseases. Journal of Clinical Medicine. 13(16). 4900–4900.
9.
Wylęgała, Adam, et al.. (2024). Endocyclophotocoagulation Combined with Phacoemulsification in Glaucoma Treatment: Five-Year Results. Biomedicines. 12(1). 186–186.
10.
Roszkowska, Anna Maria, Adam Wylęgała, Leandro Inferrera, et al.. (2023). Corneal Sub-Basal Nerve Plexus in Non-Diabetic Small Fiber Polyneuropathies and the Diagnostic Role of In Vivo Corneal Confocal Microscopy. Journal of Clinical Medicine. 12(2). 664–664. 5 indexed citations
11.
Wylęgała, Edward, et al.. (2023). Visual Acuity Examination Methodology in Keratoconus. Journal of Clinical Medicine. 12(24). 7620–7620. 3 indexed citations
12.
Wylęgała, Adam, et al.. (2022). The Ocular Surface Symptoms and Tear Film Parameters during and after COVID-19 Infection. Journal of Clinical Medicine. 11(22). 6697–6697. 1 indexed citations
13.
Teper, Sławomir, et al.. (2021). Diabetic Macular Edema Treatment with Bevacizumab Does Not Depend on the Retinal Nonperfusion Presence. Journal of Diabetes Research. 2021. 1–15. 8 indexed citations
14.
Wylęgała, Edward, et al.. (2021). Retinal OCT Findings in Patients after COVID Infection. Journal of Clinical Medicine. 10(15). 3233–3233. 23 indexed citations
15.
Wylęgała, Adam, et al.. (2021). How to Achieve Near-Normal Visual Acuity with Bevacizumab in Diabetic Macular Edema Patients. Journal of Clinical Medicine. 10(16). 3572–3572. 2 indexed citations
16.
Wylęgała, Adam, et al.. (2021). Iris-Claw Intraocular Lens Implantation in Various Clinical Indications: A 4-Year Study. Journal of Clinical Medicine. 10(6). 1199–1199. 5 indexed citations
17.
Tone, Stephan Ong, Viridiana Kocaba, Myriam Böhm, et al.. (2020). Fuchs endothelial corneal dystrophy: The vicious cycle of Fuchs pathogenesis. Progress in Retinal and Eye Research. 80. 100863–100863. 155 indexed citations
18.
Tone, Stephan Ong, et al.. (2020). Increased corneal endothelial cell migration in Fuchs endothelial corneal dystrophy, with or without TCF4 repeat expansion. Investigative Ophthalmology & Visual Science. 61(7). 1188–1188. 1 indexed citations
19.
Teper, Sławomir, Anna Nowińska, Adam Wylęgała, & Edward Wylęgała. (2018). Superficial and deep capillary plexuses evolution in retinal angiomatous proliferation during 1-year aflibercept treatment assessed by means of swept-source optical coherence tomography angiography. Investigative Ophthalmology & Visual Science. 59(9). 2393–2393. 1 indexed citations
20.
Orzechowska-Wylęgała, Bogusława, Dariusz Dobrowolski, Domenico Puzzolo, et al.. (2016). Use of Autologous Epithelium Transplantation on Various Scaffolds to Cover Tissue Loss in Oral Cavity: Long-Term Observation. Journal of Applied Biomaterials & Functional Materials. 15(1). 25–30. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026